DECONIX
Biotechnology ResearchColorado, United States2-10 Employees
DECONIX operates in biotechnology research and provides microbial remediation solutions for cannabis products. The offering targets a broad spectrum of contaminants, including Aspergillus, gram-negative bacteria, E. coli, Salmonella, Pseudomonas, coliforms, enterobacteria, aerobic bacteria, molds, yeasts, and other micro-organisms. The remediation process is patented and uses cellular cleavage to kill microbials while aiming to preserve THC levels, terpenes, cannabinoids, and the product’s appearance, taste, and smell. Their clients report success remediating cannabis with microbial loads exceeding one million CFU per gram. The company is based in Centennial, Colorado, United States, and operates with a small team. It positions itself in the cannabis safety and quality segment of biotechnology research, offering high-throughput remediation that seeks to minimize impact on product characteristics.